Now that plaquenil (hydroxychlorquinone) is being discussed as a potential treatment for coronavirus, patients with lupus, Sjogren's syndrome, rheumatoid arthritis, and other disorders who rely on plaquenil are having difficulty renewing their prescriptions. While you should always speak with your doctor before changing your treatment plan, during this webinar, Ilene Ruhoy, MD, PhD, a neurologist who specializes in integrative medicine, discusses various approaches to reducing inflammation.
This Dysautonomia International webinar was recorded April 2020.
Sign up for Dysautonomia International's email list to receive the latest dysautonomia news, events and research: [ Ссылка ]
Web: [ Ссылка ]
Facebook: [ Ссылка ]
Instagram: [ Ссылка ]
Twitter: [ Ссылка ]
Donate: [ Ссылка ]
Disclaimer: The captions and translations for this video are auto-generated by YouTube and may not be completely accurate.
